Investor Presentaiton
Novo Nordisk Annual Report 2023
Contractual undiscounted cash flows
Introducing Novo Nordisk
Strategic Aspirations
Risks
Management
Consolidated statements
Additional information
4.7 Cash and cash equivalents
4.8 Cash flow statement specifications
DKK million
Leases
Issued
Eurobonds
Bank
overdrafts
Total
DKK million
2023
2023
Cash at bank
14,392
2022
12,653
2021
Other non-cash items
10,720
DKK million
2023
2022
2021
Within 1 year
1,318
4,975
456
6,749
Borrowings (note 4.6)
(1)
1-3 years
1,902
3,948
5,850
Cash and cash equivalents
14,392
12,653
Interest income and interest expenses, net
(note 4.10)
(527)
139
10,719
3-5 years
1,253
8,695
9,948
Capital gain/(loss) on investments, net
(note 4.10)
106
124
More than 5 years
1,612
3,819
Total
6,085
21,437
456
5,431
27,978
Cash and cash equivalents at 31 December 2023 includes DKK 857 million that is
restricted (DKK 458 million in 2022). The restricted cash balance relates to subsidiaries
in which availability of currency for remittance of funds is temporarily scarce.
སྐྱ¨
58
(340)
Result of associated companies (note 4.10)
Other non-current receivables and
(81)
189
24
Carrying amount end
prepayments
(1,224)
61
407
of the year
5,726
20,824
456
Non-current liabilities
4,552
15,976
Current liabilities
1,174
4,848
456
27,006
20,528
6,478
ACCOUNTING POLICIES
Cash and cash equivalents consist of cash offset by short-term bank overdrafts. Where
short-term bank overdrafts are consistently overdrawn, they are excluded from cash
and cash equivalents. The movement in such facilities is presented under financing
activities in the cash flow statement.
Other non-current liabilities
89
(260)
Share-based payment costs (note 5.1)
2,149
1,539
1,040
2022
Within 1 year
1,088
127
480
1,695
Increase/decrease) in provisions (note 3.5)
and retirement benefit obligations
Other
32,243
19,080
16,581
(373)
1,438
(4,354)
1-3 years
1,566
8,811
10,377
Total other non-cash items
32,382
22,310
13,416
3-5 years
923
3,905
4,828
Change in working capital
More than 5 years
1,416
8,672
10,088
DKK million
2023
2022
2021
Total
4,993
21,515
480
26,988
Inventories
(7,423)
(4,767) (1,085)
Carrying amount end
of the year
4,529
20,775
480
25,784
Trade receivables
(14,210)
(9,917) (12,909)
Non-current liabilities
3,543
20,775
24,318
Other receivables and prepayments
(2,063)
(968)
(876)
Current liabilities
986
480
1,466
Trade payables
10,019
6,717
3,153
Other liabilities
5,099
4,006
2,595
Adjustment for payables related to non-
current assets
(2,432)
(1,567)
(15)
Adjustment related to acquisition of
businesses
(143) (1,409)
Change in working capital including
exchange rate adjustments
(11,010)
(6,639) (10,546)
Exchange rate adjustments
(1,235)
Cash flow change in working capital
(12,245)
1,303
(5,336) (9,063)
1,483
73View entire presentation